Diagnosis and Management of Multiple Myeloma :  A Review

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

<p class="first" id="d8853776e188">Multiple myeloma is a hematologic malignancy characterized by presence of abnormal clonal plasma cells in the bone marrow, with potential for uncontrolled growth causing destructive bone lesions, kidney injury, anemia, and hypercalcemia. Multiple myeloma is diagnosed in an estimated 34 920 people in the US and in approximately 588 161 people worldwide each year. </p>

Related collections

Author and article information

Journal

Title: JAMA

Abbreviated Title: JAMA

Publisher: American Medical Association (AMA)

ISSN (Print): 0098-7484

Publication date Created: February 01 2022

Publication date (Print): February 01 2022

Volume: 327

Issue: 5

Page: 464

Affiliations

[1 ]Division of Medical Oncology, Department of Medicine, University of Washington, Seattle

[2 ]Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

[3 ]Seattle Cancer Care Alliance, Seattle, Washington

[4 ]Division of Hematology, Department of Medicine, University of Washington, Seattle

[5 ]Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida

[6 ]Now with Bristol Myers Squibb, Seattle, Washington

Article

DOI: 10.1001/jama.2022.0003

PubMed ID: 35103762

SO-VID: d728a2bb-73cd-4bad-8934-d5013a50ee1d

History

Data availability:

Comments

Comment on this article

Cited by 325

See all cited by

- Version 1

Diagnosis and Management of Multiple Myeloma : A Review

Read this article at